Member Info for condao

LSA was valued at 410m 2 years ago...it's probably worth more now especially given the recent LHR deal. Assuming the same value and taking into account 250m of debt, there us 15p a share left for shareholders.

Forced sellers got the price down here and they have been cleared at 0.9375 just now. Volume is 147m

After hours Rns X 2 detailing the sellers from Friday. Someone has taken a 12% stake and the market has no stock on offer. Any ideas ?

Is it too simplistic to think or hope for a monthly dividend like I3E and CASP pay ?
2k barrels a day production is 730,000 a year. Assuming Brent at $75, costs of production of $41, cable at 1.20 gives net revenue (after capex of £7.9m) of £12.8m . More than enough to pay 0.33p monthly div giving a yield of 20% whilst paying off the debt and investing in the Geothermal side. I am assuming the tax losses account for the crazy windfall tax.

If somebody wanted them a bid would have happened by now. Most likely positive end scenario is a placing to a strategic investor to fund the 'growth' . But why would that person pay more than 1p as there are still 60m+ warrants out there exercisable at 1p ?

Ms Lee, Charles Street Int, Eric Simpson are all Robert Keith using different names.

Are you referring to Robert Keith who owns 25% of GFIN and obviously runs the show in the background ? Holding a similar amount of Maistro and Mporium didn't stop the the share price going to zero and plenty of retail investors left with huge losses.

There had been a decent sized seller so the MMs kept them low to take them out - which happened on Thursday.
Richard Griffiths took Woodford out a while back and owns nearly 30%.
Peel Hunt , Numis , and Finncap have price targets of between 70 and 90p.
They should be a lot higher and I'm sure they will start moving higher now the seller has been cleared and the wider market wakes up to the prospects.

It looks like I have missed the boat in this one - up 300% in 3 weeks.
A question to all FARN experts, does Diurnal (DNL) fit the bill for the next one ? It seems to be similar to FARN in that it has a small free float, lots of newsflow upcoming and products that might be worth $$$$$ on a deal.
Thoughts ?

Can anyone give a monetary read across from today's Solo rns ro CLNR's assets ?

To me Charlotte's Web (CWEB) is the closest comparison to what HNR is trying to do. Their current revenues are not that much higher than what HNR should achieve in a years time. Market cap is 2.4bn. Probably much too high but the current mcap of HNR doesn't reflect the hope/hype/future revenues at all.

Huge numbers - but remember a previously quoted ambulance chasing lawyer called Quindell - they reported massive profits but it all turned out to be scam - the profits reported were client wins booked before the cases were won. The similarities between Allay and Quindell are striking. These MPM figures seem too good to be true - with Quindell they were.
Be very careful guys.

Ali certainly knows the biotech world. The Arrowhead purchase would have been 20 bagger if he had been allowed to keep it

Futura medical and Midatech have both recently hit a market cap of 40m on the hope that their drug in development hits the jackpot in a years time. Reneuron has 3 chances at the jackpot and is fully funded to get them all to the end of their trials. It's about time the market woke up to this and as there are only 30m shares in issue the price rise should be significant.

All the CF stock has gone. As with most liquidations they sold at the wrong price. Look at the buying at 4.7.

The ex CEO of Silence Therapeutics has bought a stake. He was instrumental in buying Arrowhead for SLN before it became a multi bagger and is obviously a sector expert.

There was an announcement on Bloomberg. Someone posted it on twitter as a reply to Align's neg comment. Maybe an rns tomorrow ?

Invesco have sold out as they have been battered in Motif Bio and the fund manager is on the naughty step. I would expect the new German holder to get busy with a cash distribution or maybe even a takeover to merge with one of their own bios if they hold one, so as to utilise the tax losses. The only balance sheet that I have read is the figures from last August. I presume it's on Realm's website under investor relations - if not will it not be on this site under regulatory news ? I see zero downside, possibly a 20p bid, more likely 16p cash returned and the only risk is how long it takes.

Have a look at the holding in Co chaps

sorry forgot to write, handing back cash now to UK shareholders won't affect any potential RTO in the US as most shells have a small amount of cash with the 'purchase' price being paid in new shares to the vendor and new investors

Did you ask why they aren't offering a cash tender to UK shareholders who don't want a Nasdaq company ? If, in the future, they find a RTO an issue of new shares is inevitable anyway.